Status:
COMPLETED
Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction
Lead Sponsor:
Pfizer
Conditions:
Impotence
Eligibility:
MALE
18-65 years
Phase:
PHASE2
Brief Summary
Assessment of duration of action, safety \& toleration of different formulations and doses of UK-369,003 and Cialis in patients with male erectile dysfunction. Patients should have previously been on ...
Eligibility Criteria
Inclusion
- Erectile Dysfunction
Exclusion
- Alpha blockers and Nitrates of any preparation
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00174486
Start Date
February 1 2005
End Date
June 1 2005
Last Update
July 25 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.